LIVANOVA PLC (LIVN)

LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident

LivaNova to Announce First-Quarter 2024 Results

LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea

LIVN Crosses Below Key Moving Average Level

LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029

LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes

LivaNova to Present at the Barclays Global Healthcare Conference

Noteworthy Friday Option Activity: AMBC, LIVN, VICR

LivaNova PLC Non-GAAP EPS of $0.87 beats by $0.10, revenue of $310.1M beats by $22.4M (NASDAQ:LIVN)

LivaNova PLC beats expectations with Q4 earnings, reporting a Non-GAAP EPS of $0.87, exceeding estimates by $0.10, and a revenue of $310.1M, surpassing...

LivaNova Reports Fourth-Quarter and Full-Year 2023 Results

Bullish Two Hundred Day Moving Average Cross - LIVN

LivaNova names Vladimir Makatsaria as CEO (NASDAQ:LIVN)

LivaNova PLC announces Vladimir A. Makatsaria as new CEO, replacing William Kozy.

LivaNova Announces Vladimir A. Makatsaria as CEO and Board Director

LivaNova Breaks Above 200-Day Moving Average - Bullish for LIVN

LIVN Crosses Above Key Moving Average Level

LivaNova to wind down Advanced Circulatory Support business unit (NASDAQ:LIVN)

LivaNova announces wind down of Advanced Circulatory Support business unit to enhance focus on Cardiopulmonary and Neuromodulation Business Units.

LivaNova to Wind Down Advanced Circulatory Support Business Unit

LivaNova to Announce Fourth-Quarter and Full-Year 2023 Results

LIVN Makes Bullish Cross Above Critical Moving Average

Commit To Buy LivaNova At $35, Earn 6.3% Using Options

LivaNova reports cybersecurity incident, says IT systems disrupted (NASDAQ:LIVN)

LivaNova discloses a cybersecurity incident, causing disruptions to its IT systems and business operations.

Noteworthy Wednesday Option Activity: VLO, LIVN, CEG

LivaNova to Present at the Piper Sandler Healthcare Conference

Noteworthy Wednesday Option Activity: AVT, LIVN, XPOF

LIVN Crosses Above Key Moving Average Level

LivaNova PLC Non-GAAP EPS of $0.73 beats by $0.09, revenue of $286.1M beats by $14.24M (NASDAQ:LIVN)

LivaNova (LIVN) reports impressive Q3 results, beating expectations with Non-GAAP EPS of $0.73 and revenue of $286.1M, up 13.3% YoY.

LivaNova Reports Third-Quarter 2023 Results

LivaNova to Present at the Stifel and Wolfe Healthcare Conferences

LivaNova Board Appoints J. Christopher Barry as New Director

LivaNova Announces Marco Dolci, President of Cardiopulmonary, to Retire at the End of 2023

LivaNova to Announce Third-Quarter 2023 Results

Commit To Buy LivaNova At $47.50, Earn 8.4% Using Options